Xiao Chai Hu Tang-derived decoction (Tung-Yi Fang) suppresses triple negative breast cancer cells in vitro and in vivo via regulating EGFR/AXL-mediated signaling
Frontiers in Pharmacology · 13.03.2026 · 17
DOI: 10.3389/fphar.2026.1778030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.03.2026. Verfasst von Li-Lan Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. Xiao Chai Hu Tang (XCHT), a classical herbal formula, is prescribed as an adjuvant therapy in breast cancer care. However, the high sugar content of XCHT may influence its anticancer efficacy under modern experimental conditions. This study investigated the anti-TNBC effects of Tung-Yi Fang (TYF), a sugar-reduced XCHT-derived decoction, and elucidated its underlying mechanisms in vitro and in vivo .
Methods
TYF was chemically characterized by reverse-phase high-performance liquid chromatography. Its bioactivities were evaluated in TNBC cells using viability and colony formation assays, as well as migration/invasion, cell cycle, and apoptosis analyses. Mechanistic insights were investigated using receptor tyrosine kinase (RTK) arrays, Western blotting, and immunofluorescence analyses. The in vivo relevance of TYF was further assessed in an orthotopic 4T1-luciferase breast cancer mouse model.
Results
TYF selectively suppressed TNBC cell growth while exerting minimal effects on non-tumorigenic breast epithelial cells and fibroblasts. TYF induced G2/M cell cycle arrest and apoptotic responses. TYF impaired TNBC cell mobility through disruption of actin cytoskeletal organization and suppression of FAK/Src signaling. RTK profiling and downstream analyses revealed that TYF concurrently regulated EGFR- and AXL-associated signaling pathways, leading to attenuation of AKT, ERK, and STAT3 activation. TYF administration significantly reduced tumor growth and metastatic burden without detectable systemic toxicity in vivo .
Conclusion
TYF exhibits anti-TNBC activity through EGFR and AXL inhibition and suppression of metastatic potential. Its efficacy highlights the therapeutic potential of glucose-controlled herbal formulations in cancer management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Branch of Linsen Chinese and Kunming, Taipei City Hospital, Taipei, Taiwan.
- Traditional Chinese Medicine Glycomics Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- School of Chinese Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
- Department of Pharmacy, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Zitieren
APA
Liao, L. L., Lin, Z. H., Liaw, C. C., Yeh, H., Wang, W. H., Chen, Y. C., Lin, Y. A., Tseng, A. J., Lin, Y. C., Tsai, W. H., Chao, C. H., Lu, M. K., Hsu, C. H., & Lin, T. Y. (2026). Xiao Chai Hu Tang-derived decoction (Tung-Yi Fang) suppresses triple negative breast cancer cells in vitro and in vivo via regulating EGFR/AXL-mediated signaling. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1778030
Vancouver
Liao LL, Lin ZH, Liaw CC, Yeh H, Wang WH, Chen YC, et al. Xiao Chai Hu Tang-derived decoction (Tung-Yi Fang) suppresses triple negative breast cancer cells in vitro and in vivo via regulating EGFR/AXL-mediated signaling. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1778030
BibTeX
@article{Liao2026,
author = {Liao, Li-Lan and Lin, Zhi-Hu and Liaw, Chia-Ching and Yeh, Hsin and Wang, Wei-Hao and Chen, Yun-Chih and Lin, Yi-An and Tseng, Ai-Jung and Lin, Yu-Chun and Tsai, Wen-Hsin and Chao, Chi-Hong and Lu, Mei-Kuang and Hsu, Chung-Hua and Lin, Tung-Yi},
title = {Xiao Chai Hu Tang-derived decoction (Tung-Yi Fang) suppresses triple negative breast cancer cells in vitro and in vivo via regulating EGFR/AXL-mediated signaling},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1778030}
}
EUVIMED